Does EVEROLIMUS Cause Renal cell carcinoma? 130 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 130 reports of Renal cell carcinoma have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 0.3% of all adverse event reports for EVEROLIMUS.
130
Reports of Renal cell carcinoma with EVEROLIMUS
0.3%
of all EVEROLIMUS reports
44
Deaths
27
Hospitalizations
How Dangerous Is Renal cell carcinoma From EVEROLIMUS?
Of the 130 reports, 44 (33.8%) resulted in death, 27 (20.8%) required hospitalization, and 4 (3.1%) were considered life-threatening.
Is Renal cell carcinoma Listed in the Official Label?
Yes, Renal cell carcinoma is listed as a known adverse reaction in the official FDA drug label for EVEROLIMUS.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Renal cell carcinoma?
CABOZANTINIB S-MALATE (451)
SUNITINIB MALATE (361)
PAZOPANIB (244)
AXITINIB (154)
RANITIDINE (143)
SORAFENIB (118)
METHOTREXATE (116)
ADALIMUMAB (105)
PREDNISONE (101)
TACROLIMUS (98)
Which EVEROLIMUS Alternatives Have Lower Renal cell carcinoma Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE